Stay updated with breaking news from Davis Rea. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Davis Rea LTD. lowered its stake in Stryker Co. (NYSE:SYK – Get Rating) by 0.6% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 28,220 shares of the medical technology company’s stock after selling 166 shares during the period. Stryker accounts for about 4.3% of […]
Davis Rea LTD. reduced its holdings in shares of Royal Bank of Canada (NYSE:RY – Get Rating) (TSE:RY) by 3.2% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 50,900 shares of the financial services provider’s stock after selling 1,679 shares during the […]
Davis Rea LTD. lowered its stake in Synopsys, Inc. (NASDAQ:SNPS – Get Rating) by 10.0% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 9,222 shares of the semiconductor company’s stock after selling 1,019 shares during the period. Synopsys makes up 1.8% of Davis Rea […]
Davis Rea LTD. purchased a new position in Algonquin Power & Utilities Corp. (NYSE:AQN – Get Rating) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 10,929 shares of the utilities provider’s stock, valued at approximately $73,000. A number of other hedge funds […]
Davis Rea LTD. trimmed its stake in Thermo Fisher Scientific Inc. (NYSE:TMO – Get Rating) by 1.1% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 10,726 shares of the medical research company’s stock after selling 120 shares during the quarter. Thermo […]